Siolta Therapeutics

San Francisco Bay Area, United States · Founded 2016 · $92.3M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$92.3M
Last Round
$529K GrantAug 2025
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutic products (LBPs) targeting inflammatory and allergic diseases through manipulation of the human microbiome. Their proprietary Precision Symbiotics Platform designs multi-strain microbial consortia to prevent conditions such as atopic dermatitis and food allergy in newborns. Founded as a UCSF spinout, their lead program STMC-103H has received FDA Fast Track Designation.

Summary

Siolta Therapeutics is a Biotech company based in San Francisco Bay Area, United States, founded in 2016. It has raised $92.3M in total across 7 rounds, most recently a $529K Grant round in Aug 2025. Investors include Capital Group and Khosla Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Aug 2025
$529K

Sign up to see all 7 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Siolta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/siolta-therapeutics"><img src="https://indexed.vc/api/badge/company/siolta-therapeutics" alt="Siolta Therapeutics on Indexed.vc" width="260" height="76" /></a>